NYSE - Delayed Quote • USD
STERIS plc (STE)
At close: 4:00 PM EDT
After hours: 5:05 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 6 | 7 | 7 |
| Avg. Estimate | 2.35 | 2.13 | 8.6 | 9.33 |
| Low Estimate | 2.2 | 1.9 | 8.45 | 9 |
| High Estimate | 2.42 | 2.24 | 8.67 | 9.57 |
| Year Ago EPS | 2.3 | 2 | 8.2 | 8.6 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 4 | 8 | 8 |
| Avg. Estimate | 1.41B | 1.32B | 5.45B | 5.67B |
| Low Estimate | 1.32B | 1.24B | 5.35B | 5.36B |
| High Estimate | 1.46B | 1.38B | 5.5B | 5.85B |
| Year Ago Sales | 1.38B | 1.21B | 4.96B | 5.45B |
| Sales Growth (year/est) | 1.90% | 9.60% | 9.80% | 4.20% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2.15 | 1.87 | 2 | 2.17 |
| EPS Actual | 2.3 | 2 | 2.03 | 2.22 |
| Difference | 0.15 | 0.13 | 0.03 | 0.05 |
| Surprise % | 7.00% | 7.00% | 1.50% | 2.30% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.35 | 2.13 | 8.6 | 9.33 |
| 7 Days Ago | 2.38 | 2.13 | 8.63 | 9.38 |
| 30 Days Ago | 2.42 | 2.21 | 8.66 | 9.53 |
| 60 Days Ago | 2.42 | 2.21 | 8.66 | 9.53 |
| 90 Days Ago | 2.47 | 2.2 | 8.67 | 9.55 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | STE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 2.20% | -- | -- | 7.00% |
| Next Qtr. | 6.50% | -- | -- | 10.70% |
| Current Year | 4.90% | -- | -- | 4.50% |
| Next Year | 8.50% | -- | -- | 13.20% |
| Next 5 Years (per annum) | 10.00% | -- | -- | 10.91% |
| Past 5 Years (per annum) | 12.11% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Needham: Hold | 4/12/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/9/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/8/2024 |
| Initiated | Keybanc: Overweight | 2/6/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2023 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 11/9/2023 |
Related Tickers
GMED Globus Medical, Inc.
51.36
+2.17%
UFPT UFP Technologies, Inc.
253.04
-1.35%
SNN Smith & Nephew plc
24.93
+0.73%
SGHT Sight Sciences, Inc.
5.65
-2.92%
ITGR Integer Holdings Corporation
113.14
+1.26%
BIO Bio-Rad Laboratories, Inc.
279.91
-0.73%
EUZ.DE Eckert & Ziegler SE
39.80
+0.96%
ZIMV ZimVie Inc.
16.05
+1.45%
TMCI Treace Medical Concepts, Inc.
11.12
-0.80%
CNMD CONMED Corporation
71.65
+1.27%